Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia.

CONCLUSIONS: Survival rates are low in pediatric and young-adult patients who relapse after first and second allo-SCT, and new therapies are needed to improve outcome in this population. These data can be used as historical comparisons for single-arm trials of novel therapies for this patient population, including chimeric antigen receptor T-cell therapy. PMID: 28945102 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research